title: Barrett esophagus after chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF): an iatrogenic injury?
authors.affiliation: St. Anna General Hospital, Ferrara, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Sartori
authors.forename: I
authors.initials: I
authors.lastname: Nielsen
authors.forename: M
authors.initials: M
authors.lastname: Indelli
authors.forename: L
authors.initials: L
authors.lastname: Trevisani
authors.forename: P
authors.initials: P
authors.lastname: Pazzi
authors.forename: E
authors.initials: E
authors.lastname: Grandi
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001471:Barrett Esophagus / Q000139:chemically induced* / Q000175:diagnosis; D001706:Biopsy; D001943:Breast Neoplasms / Q000188:drug therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004945:Esophagoscopy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011446:Prospective Studies
chemical_list: D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate